🇺🇸 FDA

Company profile · Sponsor

Verrica

Verrica Pharmaceuticals

VRCA · NYSE pharma WEST CHESTER, PA, USA
Pipeline
7
Drugs
1
Patents
7

Quick answer

Verrica (VRCA) is a pharma company. headquartered in WEST CHESTER, PA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 1 drug, and 7 patents to this profile..

Company facts

Ticker VRCA
Exchange NYSE
Company type pharma
Headquarters WEST CHESTER, PA, USA
SEC CIK 0001660334

Pipeline (7)

Search pipeline →

  1. Cantharidin

    Verrica

    Common Warts (Verruca Vulgaris)

    phase 3 other active

    1 trial

  2. VP-102

    Verrica

    Common Warts

    phase 3 other active

    1 trial

  3. VP-102 - Cantharidin, Topical Film Forming Solution

    Verrica

    Molluscum Contagiosum

    phase 3 other completed

    2 trials

  4. Part 1: VP-315 3 Day Dosing/Week

    Verrica

    Basal Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  5. VP-102 Cantharidin topical film forming solution

    Verrica

    Common Wart

    phase 2 other completed

    1 trial

  6. VP-102 and applicator

    Verrica

    Condylomata Acuminata

    phase 2 other completed

    1 trial

  7. VP-102 with applicator

    Verrica

    Molluscum Contagiosum

    phase 2 other completed

    1 trial

Drugs (1)

Search drugs →

  1. cantharidin

    YCANTH

    TOPICAL approved

Patents (7)

Search patents →

  1. US 12290651

    Devices and methods for the treatment of body surface disorders

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12233042

    Treatment of cutaneous disorders

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12221452

    Synthesis of cantharidin

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11168091

    Quantification and preparation of pharmaceutical grade cantharidin

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11147790

    Treatment of cutaneous disorders

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11052064

    Compositions, methods and systems for the treatment of cutaneous disorders

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10745413

    Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Verrica?

Verrica (VRCA) is a pharma company. headquartered in WEST CHESTER, PA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 1 drug, and 7 patents to this profile..

What pipeline programs does Verrica sponsor?

We track 7 ClinicalTrials.gov-linked programs for Verrica, including Cantharidin and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Verrica company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.